Cargando…
Optimal Management of Severe/Refractory Asthma
Asthma is a chronic inflammatory disease of the airways, affecting approximately 300 million people worldwide. Asthma results in airway hyperresponsiveness, leading to paroxysmal symptoms of wheeze, cough, shortness of breath, and chest tightness. When these symptoms remain uncontrolled, despite tre...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165919/ https://www.ncbi.nlm.nih.gov/pubmed/21912491 http://dx.doi.org/10.4137/CCRPM.S5535 |
_version_ | 1782211098326335488 |
---|---|
author | Pakhale, Smita Mulpuru, Sunita Boyd, Matthew |
author_facet | Pakhale, Smita Mulpuru, Sunita Boyd, Matthew |
author_sort | Pakhale, Smita |
collection | PubMed |
description | Asthma is a chronic inflammatory disease of the airways, affecting approximately 300 million people worldwide. Asthma results in airway hyperresponsiveness, leading to paroxysmal symptoms of wheeze, cough, shortness of breath, and chest tightness. When these symptoms remain uncontrolled, despite treatment with high doses of inhaled and ingested corticosteroids, asthmatic patients are predisposed to greater morbidity and require more health care support. Treating patients with severe asthma can be difficult and often poses a challenge to physicians when providing ongoing management. This clinical review aims to discuss the definition, prevalence and evaluation of severe asthmatics, and provides a review of the existing pharmacologic and non-pharmacologic treatment options. |
format | Online Article Text |
id | pubmed-3165919 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Libertas Academica |
record_format | MEDLINE/PubMed |
spelling | pubmed-31659192011-09-12 Optimal Management of Severe/Refractory Asthma Pakhale, Smita Mulpuru, Sunita Boyd, Matthew Clin Med Insights Circ Respir Pulm Med Review Asthma is a chronic inflammatory disease of the airways, affecting approximately 300 million people worldwide. Asthma results in airway hyperresponsiveness, leading to paroxysmal symptoms of wheeze, cough, shortness of breath, and chest tightness. When these symptoms remain uncontrolled, despite treatment with high doses of inhaled and ingested corticosteroids, asthmatic patients are predisposed to greater morbidity and require more health care support. Treating patients with severe asthma can be difficult and often poses a challenge to physicians when providing ongoing management. This clinical review aims to discuss the definition, prevalence and evaluation of severe asthmatics, and provides a review of the existing pharmacologic and non-pharmacologic treatment options. Libertas Academica 2011-08-31 /pmc/articles/PMC3165919/ /pubmed/21912491 http://dx.doi.org/10.4137/CCRPM.S5535 Text en © the author(s), publisher and licensee Libertas Academica Ltd. This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited. |
spellingShingle | Review Pakhale, Smita Mulpuru, Sunita Boyd, Matthew Optimal Management of Severe/Refractory Asthma |
title | Optimal Management of Severe/Refractory Asthma |
title_full | Optimal Management of Severe/Refractory Asthma |
title_fullStr | Optimal Management of Severe/Refractory Asthma |
title_full_unstemmed | Optimal Management of Severe/Refractory Asthma |
title_short | Optimal Management of Severe/Refractory Asthma |
title_sort | optimal management of severe/refractory asthma |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165919/ https://www.ncbi.nlm.nih.gov/pubmed/21912491 http://dx.doi.org/10.4137/CCRPM.S5535 |
work_keys_str_mv | AT pakhalesmita optimalmanagementofsevererefractoryasthma AT mulpurusunita optimalmanagementofsevererefractoryasthma AT boydmatthew optimalmanagementofsevererefractoryasthma |